Prevalence of SARS-Cov-2 antibodies and living conditions: the French national random population-based EPICOV cohort.
Warszawski J, Beaumont AL, Seng R, de Lamballerie X, Rahib D, Lydié N, Slama R, Durrleman S, Raynaud P, Sillard P, Beck F, Meyer L, Bajos N; EPICOV study group.
Warszawski J, et al. Among authors: lydie n.
BMC Infect Dis. 2022 Jan 9;22(1):41. doi: 10.1186/s12879-021-06973-0.
BMC Infect Dis. 2022.
PMID: 35000580
Free PMC article.